These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30508603)

  • 1. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
    John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
    Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant
    Panya A; Sawasdee N; Songprakhon P; Tragoolpua Y; Rotarayanont S; Choowongkomon K; Yenchitsomanus PT
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33172110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
    Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of silymarin and baicalein against dengue virus.
    Low ZX; OuYong BM; Hassandarvish P; Poh CL; Ramanathan B
    Sci Rep; 2021 Oct; 11(1):21221. PubMed ID: 34707245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
    Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
    Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial peptide HS-1 inhibits dengue virus infection.
    Monteiro JMC; Oliveira MD; Dias RS; Nacif-Marçal L; Feio RN; Ferreira SO; Oliveira LL; Silva CC; Paula SO
    Virology; 2018 Jan; 514():79-87. PubMed ID: 29153860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
    Chew MF; Tham HW; Rajik M; Sharifah SH
    J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
    Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel antiviral peptides against dengue serotypes 1-4.
    Lee MF; Anasir MI; Poh CL
    Virology; 2023 Mar; 580():10-27. PubMed ID: 36739680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
    Laosutthipong C; Kanthong N; Flegel TW
    Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
    Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB
    Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide inhibitors of dengue virus and West Nile virus infectivity.
    Hrobowski YM; Garry RF; Michael SF
    Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing of quinine as antiviral against dengue virus infection.
    Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
    Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
    Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
    Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
    Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
    Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
    Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.